SCHEMBL6779600

SCHEMBL6779600

CC1(C)CCC(C)(C)c2cc(CNc3ccc(I)cc3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
CYP26A1 O43174 9/20 0.42
CYP26B1 Q9NR63 6/20 0.42
HIF1A Q16665 1/20 0.42
EPAS1 Q99814 1/20 0.42
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RARA P10276 3/20 0.38
RARB P10826 3/20 0.38
RARG P13631 3/20 0.38
MEN1 O00255 2/20 0.38
CYP3A4 P08684 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458958 0.81 RXRA (0.69) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL8259674 0.76 RXRA (0.54) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL4593508 0.73 RXRA (0.44) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL8059199 0.73 HIF1A (0.59) HIF1AEPAS1ALDH1A1MAPTKDM4E
SCHEMBL5888067 0.72 RARB (0.66) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL6004955 0.72 CYP26A1 (0.53) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL2195316 0.72 RXRA (0.47) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL9747007 0.71 RARA (0.62) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL8677671 0.70 CYP3A4 (0.61) RXRARXRBRXRGCYP26A1CYP26B1
SCHEMBL25547420 0.70 HTT (0.53) ALDH1A1MAPTKDM4EGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT RXRA 1980/4885RXRB 1693/4885RXRG 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.